Independent of cell line tested and relative to complemented controls, IPMK KO and IPPK KO reduced HIV-1 infection by greater than 10-fold upon dosing cells with 0.78 or 1.56 nM LCV, respectively. This evidence concerns the gene IPMK and HIV-1 infection.